ClinConnect ClinConnect Logo
Search / Trial NCT06047223

Analysis of Brain Diffusion Tensor Image in Stroke Patients

Launched by BUNDANG CHA HOSPITAL · Sep 14, 2023

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how brain imaging can help us understand the differences in stroke patients. Researchers will use a special type of MRI called diffusion tensor imaging to look at brain activity and structure in stroke patients. The goal is to see how these brain images relate to patients' blood test results and their neurological (nervous system) function at the same time. By doing this, the study hopes to gather important information that can improve care for stroke patients.

To participate in this study, individuals must be at least 20 years old and have a history of stroke. It’s important that they can understand the study and give their consent to join. However, people with severe health issues, certain medical devices, or those who cannot provide consent cannot take part. Participants can expect to undergo brain imaging and have their health information compared, which could contribute to a better understanding of stroke recovery. This study is currently recruiting, and anyone interested should consider discussing it with their healthcare provider.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adults aged 20 years or older with a history of stroke
  • 2. After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions
  • Exclusion Criteria:
  • Patients who meet one or more of the following cannot participate in the study.
  • 1. Those with severe medical conditions such as unstable conditions in the cardiovascular system, digestive system, respiratory system, endocrine system, etc., and those with poor general health
  • 2. In the case of a person with impaired consent, a person without a guardian
  • 3. Patients who have devices that may be affected by MRI, such as pacemakers, spinal cord stimulators, cochlear implants, VP shunts, and nerve stimulators, inserted into the body
  • 4. Other cases where the researcher judges that participation in this study is not suitable (This study is not an interventional study, and patients who are participating in other clinical trials or studies or who have participated in other clinical trials or studies within the past 30 days can also participate in this study.)

About Bundang Cha Hospital

Bundang CHA Hospital is a leading healthcare institution located in South Korea, renowned for its commitment to innovative medical research and patient-centered care. As a prominent clinical trial sponsor, the hospital leverages its advanced facilities and multidisciplinary expertise to conduct rigorous clinical studies across various therapeutic areas. With a focus on advancing medical knowledge and improving treatment outcomes, Bundang CHA Hospital collaborates with a network of esteemed researchers and healthcare professionals to ensure the highest standards of clinical excellence and ethical practices in all its trials.

Locations

Seongnam Si, Gyeonggi Do, Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Minyoung Kim, M.D., Ph.D.

Principal Investigator

Bundang CHA Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported